Literature DB >> 2195041

c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts display more decondensed nucleosomal organization than normal fibroblasts.

J Laitinen1, L Sistonen, K Alitalo, E Hölttä.   

Abstract

We have compared the nucleosomal organization of c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts with that of normal fibroblasts by using micrococcal nuclease (MNase) as a probe for the chromatin structure. The bulk chromatin from asynchronously and exponentially growing ras-transformed cells was much more sensitive to MNase digestion than chromatin from the normal cells. Southern hybridization analyses of the MNase digests with probes specific for the ornithine decarboxylase (odc) and c-myc genes showed that the coding and/or 3' end regions of these growth-inducible genes carry a nucleosomal organization both in ras-transformed and normal cells. Studies with cells synchronized by serum starvation showed that in both cell lines the nucleosomal organization of chromatin is relatively condensed at the quiescent state, becomes highly decondensed during the late G1 phase of the cell cycle, and starts again to condense during the S phase. However, in ras-transformed cells the decondensation state stayed much longer than in normal cells. Moreover, irrespective of the phase of the cell cycle the bulk chromatin as well as that of the odc and c-myc genes was more sensitive to MNase digestion in the ras-transformed cell than in the normal fibroblast. Decondensation of the chromatin was also observed in the normal c-Ha-ras protooncogene-transfected cells, but to a lesser extent than in the mutant ras-transformed cells. Whether the increased degree of chromatin decondensation plays a regulatory role in the increased expression of many growth-related genes in the ras-transformed cells remains an interesting object of further study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2195041      PMCID: PMC2116149          DOI: 10.1083/jcb.111.1.9

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  38 in total

1.  Electron microscopy of defined lengths of chromatin.

Authors:  J T Finch; M Noll; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

2.  H1 histone and the condensation of chromatin and DNA.

Authors:  R D Cole; G M Lawson; M W Hsiang
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1978

Review 3.  Isolation and characterization of chromatin subunits.

Authors:  R L Rill; B R Shaw; K E Van Holde
Journal:  Methods Cell Biol       Date:  1978       Impact factor: 1.441

4.  The chromatin structure of specific genes: II. Disruption of chromatin structure during gene activity.

Authors:  C Wu; Y C Wong; S C Elgin
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

5.  Biochemical evidence of variability in the DNA repeat length in the chromatin of higher eukaryotes.

Authors:  J L Compton; M Bellard; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

6.  Chromatin freeze fracture electron microscopy: a comparative study of core particles, chromatin, metaphase chromosomes, and nuclei.

Authors:  J Lepault; S Bram; J Escaig; W Wray
Journal:  Nucleic Acids Res       Date:  1980-01-25       Impact factor: 16.971

7.  Reversible dissociation of linker histone from chromatin with preservation of internucleosomal repeat.

Authors:  J Allan; D Z Staynov; H Gould
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

8.  Chromatin structure and the cell cycle.

Authors:  T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

9.  Chromatin structure through the cell cycle. Studies with regeneration rat liver.

Authors:  A Caplan; M G Ord; L A Stocken
Journal:  Biochem J       Date:  1978-08-15       Impact factor: 3.857

10.  Chicken histone H5 inhibits transcription and replication when introduced into proliferating cells by microinjection.

Authors:  M G Bergman; E Wawra; M Winge
Journal:  J Cell Sci       Date:  1988-10       Impact factor: 5.285

View more
  7 in total

1.  Transcriptional and posttranscriptional regulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase during liver regeneration.

Authors:  J L Rosa; A Tauler; A J Lange; S J Pilkis; R Bartrons
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape.

Authors:  Behnam Nabet; Pilib Ó Broin; Jaime M Reyes; Kevin Shieh; Charles Y Lin; Christine M Will; Relja Popovic; Teresa Ezponda; James E Bradner; Aaron A Golden; Jonathan D Licht
Journal:  Cell Rep       Date:  2015-08-13       Impact factor: 9.423

3.  Change in the expression of a nuclear matrix-associated protein is correlated with cellular transformation.

Authors:  C Brancolini; C Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Increased histone H1 phosphorylation and relaxed chromatin structure in Rb-deficient fibroblasts.

Authors:  R E Herrera; F Chen; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 5.  Cancer cells' epigenetic composition and predisposition to histone deacetylase inhibitor sensitization.

Authors:  Narasimharao Nalabothula; France Carrier
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

6.  Chromatin changes in cell transformation: progressive unfolding of the higher-order structure during the evolution of rat hepatocyte nodules. A differential scanning calorimetry study.

Authors:  P Barboro; A Pasini; S Parodi; C Balbi; B Cavazza; C Allera; G Lazzarini; E Patrone
Journal:  Biophys J       Date:  1993-10       Impact factor: 4.033

7.  Inhibition of cytotoxic T lymphocyte-induced target cell DNA fragmentation, but not lysis, by inhibitors of DNA topoisomerases I and II.

Authors:  W K Nishioka; R M Welsh
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.